About
Dr. Strickland has a strong academic interest in brain tumor and skull base surgery. During his training, he completed an NIH research year investigating differential epigenetic expression patterns in meningioma. He has published over 130 peer-reviewed articles and dozens of book chapters and has received several grants, mostly focusing on brain and skull base tumors. He runs a laboratory to translate basic cancer immunology into novel therapies against aggressive meningioma and glioblastoma. He aims to develop targeted immunotherapies against tumors not amendable to surgical interventions.